Disorders of protein biogenesis and stability

Protein and Peptide Letters

Volumn 18, Issue 2, 2011, Pages 110-121

  Anderson, John F ^a   Siller, Efraín ^a   Barral, José M ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Chaperone; Degradation; Mutation; Protein folding; Protein synthesis; Translation

Indexed keywords

PROTEIN; TRANSFER RNA;

ARTICLE; GENETICS; HUMAN; METABOLISM; MUTATION; PROTEIN PROCESSING; PROTEIN STABILITY; PROTEIN SYNTHESIS; PROTEOSTASIS DEFICIENCY;

HUMANS; MUTATION; PROTEIN BIOSYNTHESIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STABILITY; PROTEINS; PROTEOSTASIS DEFICIENCIES; RNA, TRANSFER;

EID: 79952169994     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986611794475075     Document Type: Article

References (145)

1. Bukau, B.; Weissman, J.; Horwich, A. Molecular chaperones and protein quality control. Cell, 2006, 725(3), 443-451.
2. Kubota, H. Quality control against misfolded proteins in the cytosol: a network for cell survival. J. Biochem, 2009, 146(5), 609-616.
3. Schmeing, T. M.; Ramakrishnan, V. What recent ribosome structures have revealed about the mechanism of translation. Nature, 2009, 461(7268), 1234-1242.
4. Steitz, T. A. A structural understanding of the dynamic ribosome machine. Nat. Rev. Mol. Cell Biol, 2008, 9(3), 242-253. (Pubitemid 351301830)
5. Hartl, F. U.; Hayer-Hartl, M. Converging concepts of protein folding in vitro and in vivo. Nat. Struct. Mol. Biol, 2009, 76(6), 574-581.
6. Knecht, E.; Aguado, C; Carcel, J.; Esteban, I.; Esteve, J. M.; Ghislat, G.; Moruno, J. F.; Vidal, J. M.; Saez, R. Intracellular protein degradation in mammalian cells: recent developments. Cell Mol. Life Sci., 2009, 66(15), 2427-2443.
7. Naiki, H.; Nagai, Y. Molecular pathogenesis of protein misfolding diseases: pathological molecular environments versus quality control systems against misfolded proteins. J. Biochem., 2009, 146(6), 751-756.
8. Gregersen, N.; Bross, P.; Vang, S.; Christensen, J. H. Protein mis-folding and human disease. Annu. Rev. Genomics Hum. Genet., 2006, 7, 103-124.
9. Nureki, O.; Vassylyev, D. G.; Tateno, M.; Shimada, A.; Nakama, T.; Fukai, S.; Konno, M.; Hendrickson, T. L.; Schimmel, P.; Yoko-yama, S. Enzyme structure with two catalytic sites for double-sieve selection of substrate. Science, 1998, 280(5363), 578-582. (Pubitemid 28227759)
10. Fukai, S.; Nureki, O.; Sekine, S.; Shimada, A.; Tao, J.; Vassylyev, D. G.; Yokoyama, S. Structural basis for double-sieve discrimination of L-valine from L-isoleucine and L-threonine by the complex of tRNA(Val) and valyl-tRNA synthetase. Cell, 2000, 105(5), 793-803.
11. Ramakrishnan, V. Unraveling the structure of the ribosome (Nobel Lecture). Angew Chem. Int. Ed. Engl., 2010, 49(26), 4355-4380.
12. Yonath, A. Polar bears, antibiotics, and the evolving ribosome (Nobel Lecture). Angew Chem. Int. Ed. Engl., 2010, 49(26), 4341-4354.
13. Steitz, T. A. From the structure and function of the ribosome to new antibiotics (Nobel Lecture). Angew Chem. Int. Ed. Engl., 2010, 2010, 49(26), 4381-4398.
14. Tsai, C. J.; Sauna, Z. E.; Kimchi-Sarfaty, C.; Ambudkar, S. V.; Gottesman, M. M.; Nussinov, R. Synonymous mutations and ribo-some stalling can lead to altered folding pathways and distinct minima. J. Mol. Biol., 2008, 383(2), 281-291.
15. Sorensen, M. A.; Pedersen, S. Absolute in vivo translation rates of individual codons in Escherichia coli. The two glutamic acid codons GAA and GAG are translated with a threefold difference in rate. J. Mol. Biol., 1991, 222(2), 265-280. (Pubitemid 121004006)
16. Komar, A. A. A pause for thought along the co-translational folding pathway. Trends Biochem. Sci., 2009, 34(1), 16-24.
17. Purvis, I. J.; Bettany, A. J.; Santiago, T. C.; Coggins, J. R.; Duncan, K.; Eason, R.; Brown, A. J. The efficiency of folding of some proteins is increased by controlled rates of translation in vivo. A hypothesis. J. Mol. Biol., 1987, 193(2), 413-417.
18. Siller, E.; Dezwaan, D. C.; Anderson, J. F.; Freeman, B. C.; Barral, J. M. Slowing bacterial translation speed enhances eukaryotic protein folding efficiency. J. Mol. Biol., 2010, 369(5), 1310-1318.
19. Zhang, G.; Hubalewska, M.; Ignatova, Z. Transient ribosomal attenuation coordinates protein synthesis and co-translational folding. Nat. Struct. Mol. Biol., 2009, 16(3), 274-280.
20. Sharp, P. M.; Li, W. H. The codon Adaptation Index-a measure of directional synonymous codon usage bias, and its potential applications. Nucleic Acids Res., 1987, 15(3), 1281-1295.
21. Saunders, R.; Deane, C. M. Synonymous codon usage influences the local protein structure observed. Nucleic Acids Res., 2010, 28(19), 6719-6728.
22. Kudla, G.; Murray, A. W.; Tollervey, D.; Plotkin, J. B. Coding-sequence determinants of gene expression in Escherichia coli. Science, 2009, 324(5924), 255-258.
23. Chang, H. C.; Kaiser, C. M.; Hartl, F. U.; Barral, J. M. De novo folding of GFP fusion proteins: high efficiency in eukaryotes but not in bacteria. J. Mol. Biol., 2005, 353(2), 397-409. (Pubitemid 41356620)
24. Netzer, W. J.; Hartl, F. U. Recombination of protein domains facilitated by co-translational folding in eukaryotes. Nature, 1997, 388(6640), 343-349. (Pubitemid 27334805)
25. Agashe, V. R.; Guha, S.; Chang, H. C.; Genevaux, P.; Hayer-Hartl, M.; Stemp, M.; Georgopoulos, C.; Hartl, F. U.; Barral, J. M. Function of trigger factor and DnaK in multidomain protein folding: increase in yield at the expense of folding speed. Cell, 2004, 117(2), 199-209. (Pubitemid 38496240)
26. Kaiser, C. M.; Chang, H. C.; Agashe, V. R.; Lakshmipathy, S. K.; Etchells, S. A.; Hayer-Hartl, M.; Hartl, F. U.; Barral, J. M. Realtime observation of trigger factor function on translating ribo-somes. Nature, 2006, 444(7118), 455-460. (Pubitemid 44809058)
27. Varenne, S.; Buc, J.; Lloubes, R.; Lazdunski, C. Translation is a non-uniform process. Effect of tRNA availability on the rate of elongation of nascent polypeptide chains. J. Mol. Biol., 1984, 180(3), 549-576.
28. Schmid, F. X. Prolyl isomerases. Adv. Protein Chem., 2001, 59, 243-282. (Pubitemid 34169307)
29. Gleiter, S.; Bardwell, J. C. Disulfide bond isomerization in pro-karyotes. Biochim. Biophys. Acta, 2008, 1783(4), 530-534.
30. Wilkinson, B.; Gilbert, H. F. Protein disulfide isomerase. Biochim. Biophys. Acta, 2004, 1699(1-2), 35-44. (Pubitemid 38680792)
31. Walsh, C. T.; Garneau-Tsodikova, S.; Gatto, G. J., Jr. Protein post-translational modifications: the chemistry of proteome diversifications. Angew Chem. Int. Ed. Engl., 2005, 44(45), 7342-7372. (Pubitemid 41689988)
32. Dulyaninova, N. G.; Malashkevich, V. N.; Almo, S. C.; Bresnick, A. R. Regulation of myosin-IIA assembly and Mts1 binding by heavy chain phosphorylation. Biochemistry, 2005, 44(18), 6867-6876. (Pubitemid 40632405)
33. Hulmes, D. J. Building collagen molecules, fibrils, and suprafibrillar structures. J. Struct. Biol., 2002, 137(1-2), 2-10. (Pubitemid 35430415)
34. Kim, J.; Lowe, T.; Hoppe, T. Protein quality control gets muscle into shape. Trends Cell Biol., 2008, 18(6), 264-272.
35. Yen, H. C.; Xu, Q.; Chou, D. M.; Zhao, Z.; Elledge, S. J. Global protein stability profiling in mammalian cells. Science, 2008, 322(5903), 918-923.
36. Konstantinova, I. M.; Tsimokha, A. S.; Mittenberg, A. G. Role of proteasomes in cellular regulation. Int. Rev. Cell Mol. Biol., 2008, 267(59-124.
37. Jung, T.; Catalgol, B.; Grune, T. The proteasomal system. Mol. Aspects Med., 2009, 30(4), 191-296.
38. Cuervo, A. M.; Dice, J. F. Lysosomes, a meeting point of proteins, chaperones, and proteases. J. Mol. Med., 1998, 76(1), 6-12. (Pubitemid 28085056)
39. Ciechanover, A. Proteolysis: from the lysosome to ubiquitin and the proteasome. Nat. Rev. Mol. Cell Biol., 2005, 6(1), 79-87.
40. Mogk, A.; Haslberger, T.; Tessarz, P.; Bukau, B. Common and specific mechanisms of AAA+proteins involved in protein quality control. Biochem. Soc. Trans., 2008, 36(Pt 1), 120-125. (Pubitemid 351269634)
41. Pickart, C. M.; Eddins, M. J. Ubiquitin: structures, functions, mechanisms. Biochim. Biophys. Acta, 2004, 1695(1-3), 55-72. (Pubitemid 39585154)
42. Tanaka, K.; Suzuki, T.; Chiba, T. The ligation systems for ubiquitin and ubiquitin-like proteins. Mol. Cells, 1998, 8(5), 503-512. (Pubitemid 128488861)
43. Antonellis, A.; Lee-Lin, S. Q.; Wasterlain, A.; Leo, P.; Quezado, M.; Goldfarb, L. G.; Myung, K.; Burgess, S.; Fischbeck, K. H.; Green, E. D. Functional analyses of glycyl-tRNA synthetase mutations suggest a key role for tRNA-charging enzymes in peripheral axons. J. Neurosci., 2006, 26(41), 10397-10406. (Pubitemid 44564590)
44. Skre, H. Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin. Genet., 1974, 6(2), 98-118.
45. Gemignani, F.; Marbini, A. Charcot-Marie-Tooth disease (CMT): distinctive phenotypic and genotypic features in CMT type 2. J. Neurol. Sci., 2001, 184(1), 1-9. (Pubitemid 32166718)
46. Ionasescu, V.; Searby, C.; Sheffield, V. C.; Roklina, T.; Nishimura, D.; Ionasescu, R. Autosomal dominant Charcot-Marie-Tooth axonal neuropathy mapped on chromosome 7p (CMT2D). Hum. Mol. Genet., 1996, 5(9), 1373-1375. (Pubitemid 26335858)
47. Antonellis, A.; Ellsworth, R. E.; Sambuughin, N.; Puls, I.; Abel, A.; Lee-Lin, S. Q.; Jordanova, A.; Kremensky, I.; Christodoulou, K.; Middleton, L. T.; Sivakumar, K.; Ionasescu, V.; Funalot, B.; Vance, J. M.; Goldfarb, L. G.; Fischbeck, K. H.; Green, E. D. Gly-cyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am. J. Hum. Genet., 2003, 72(5), 1293-1299. (Pubitemid 36530017)
48. Xie, W.; Nangle, L. A.; Zhang, W.; Schimmel, P.; Yang, X. L. Long-range structural effects of a Charcot-Marie-Tooth disease-causing mutation in human glycyl-tRNA synthetase. Proc. Natl. Acad. Sci. USA, 2007, 104(24), 9976-9981. (Pubitemid 47175248)
49. Nangle, L. A.; Zhang, W.; Xie, W.; Yang, X. L.; Schimmel, P. Charcot-Marie-Tooth disease-associated mutant tRNA synthetases linked to altered dimer interface and neurite distribution defect. Proc. Natl. Acad. Sci. USA, 2007, 104(27), 11239-11244. (Pubitemid 47175125)
50. Narla, A.; Ebert, B. L. Ribosomopathies: human disorders of ribo-some dysfunction. Blood, 2010, 115(16), 3196-3205.
51. Draptchinskaia, N.; Gustavsson, P.; Andersson, B.; Pettersson, M.; Willig, T. N.; Dianzani, I.; Ball, S.; Tchernia, G.; Klar, J.; Matsson, H.; Tentler, D.; Mohandas, N.; Carlsson, B.; Dahl, N. The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat. Genet., 1999, 21(2), 169-175. (Pubitemid 29070361)
52. Janov, A. J.; Leong, T.; Nathan, D. G.; Guinan, E. C. Diamond-Blackfan anemia. Natural history and sequelae of treatment. Medicine (Baltimore), 1996, 75(2), 77-78.
53. Willig, T. N.; Gazda, H.; Sieff, C. A. Diamond-Blackfan anemia. Curr. Opin. Hematol., 2000, 7(2), 85-94. (Pubitemid 30106539)
54. Leger-Silvestre, I.; Caffrey, J. M.; Dawaliby, R.; Alvarez-Arias, D. A.; Gas, N.; Bertolone, S. J.; Gleizes, P. E.; Ellis, S. R. Specific role for yeast homologs of the diamond blackfan anemia-associated Rps19 protein in ribosome synthesis. J. Biol. Chem., 2005, 280(46), 38177-38185. (Pubitemid 43853712)
55. Angelini, M.; Cannata, S.; Mercaldo, V.; Gibello, L.; Santoro, C.; Dianzani, I.; Loreni, F. Missense mutations associated with Diamond-Blackfan anemia affect the assembly of ribosomal protein S19 into the ribosome. Hum. Mol. Genet., 2007, 76(14), 1720-1727. (Pubitemid 47241831)
56. Badhai, J.; Frojmark, A. S.; Razzaghian, H. R.; Davey, E.; Schuster, J.; Dahl, N. Posttranscriptional down-regulation of small ribo-somal subunit proteins correlates with reduction of 18S rRNA in RPS19 deficiency. FEBS Lett., 2009, 583(12), 2049-2053.
57. Robledo, S.; Idol, R. A.; Crimmins, D. L.; Ladenson, J. H.; Mason, P. J.; Bessler, M. The role of human ribosomal proteins in the maturation of rRNA and ribosome production. Rna, 2008, 74(9), 1918-1929.
58. Filip, A. M.; Klug, J.; Cayli, S.; Frohlich, S.; Henke, T.; Lacher, P.; Eickhoff, R.; Bulau, P.; Linder, M.; Carlsson-Skwirut, C.; Leng, L.; Bucala, R.; Kraemer, S.; Bernhagen, J.; Meinhardt, A. Ribosomal protein S19 interacts with macrophage migration inhibitory factor and attenuates its pro-inflammatory function. J. Biol. Chem., 2009, 284(12), 7977-7985.
59. Danilova, N.; Sakamoto, K. M.; Lin, S. Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities and defective erythropoiesis through activation of p53 protein family. Blood, 2008, 112(13), 5228-5237.
60. McGowan, K. A.; Li, J. Z.; Park, C. Y.; Beaudry, V.; Tabor, H. K.; Sabnis, A. J.; Zhang, W.; Fuchs, H.; de Angelis, M. H.; Myers, R. M.; Attardi, L. D.; Barsh, G. S. Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects. Nat. Genet., 2008, 40(8), 963-970.
61. Ambudkar, S. V.; Kimchi-Sarfaty, C.; Sauna, Z. E.; Gottesman, M. M. P-glycoprotein: from genomics to mechanism. Oncogene, 2003, 22(47), 7468-7485. (Pubitemid 37487170)
62. Kim, R. B.; Fromm, M. F.; Wandel, C.; Leake, B.; Wood, A. J.; Roden, D. M.; Wilkinson, G. R. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J. Clin. Invest., 1998, 101(2), 289-294. (Pubitemid 28067324)
63. Pauli-Magnus, C.; Kroetz, D. L. Functional implications of genetic polymorphisms in the multidrug resistance gene MDR1 (ABCB1). Pharm. Res., 2004, 21(6), 904-913. (Pubitemid 38870137)
64. Seelig, A.; Blatter, X. L.; Wohnsland, F. Substrate recognition by P-glycoprotein and the multidrug resistance-associated protein MRP1: a comparison. Int. J. Clin. Pharmacol. Ther., 2000, 38(3), 111-121. (Pubitemid 30143145)
65. Ng, I. O.; Liu, C. L.; Fan, S. T.; Ng, M. Expression of P-glycoprotein in hepatocellular carcinoma. A determinant of chemotherapy response. Am. J. Clin. Pathol., 2000, 773(3), 355-363. (Pubitemid 30217382)
66. Kioka, N.; Tsubota, J.; Kakehi, Y.; Komano, T.; Gottesman, M. M.; Pastan, I.; Ueda, K. P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance. Biochem. Biophys. Res. Commun., 1989, 162(1), 224-231. (Pubitemid 19185850)
67. Chen, G.; Duran, G. E.; Steger, K. A.; Lacayo, N. J.; Jaffrezou, J. P.; Dumontet, C.; Sikic, B. I. Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype, and resistance to cyclosporins. J. Biol. Chem., 1997, 272(9), 5974-5982. (Pubitemid 27102435)
68. Hoffmeyer, S.; Burk, O.; von Richter, O.; Arnold, H. P.; Brock-moller, J.; Johne, A.; Cascorbi, I.; Gerloff, T.; Roots, I.; Eichel-baum, M.; Brinkmann, U. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc. Natl. Acad. Sci. USA, 2000, 97(7), 3473-3478. (Pubitemid 30183327)
69. Kimchi-Sarfaty, C.; Oh, J. M.; Kim, I. W.; Sauna, Z. E.; Calcagno, A. M.; Ambudkar, S. V.; Gottesman, M. M. A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science, 2007, 315(5811), 525-528. (Pubitemid 46175758)
70. Barral, J. M.; Broadley, S. A.; Schaffar, G.; Hartl, F. U. Roles of molecular chaperones in protein misfolding diseases. Semin. Cell Dev. Biol., 2004, 15(1), 17-29. (Pubitemid 38177364)
71. Macario, A. J.; Conway de Macario, E. Chaperonopathies and chaperonotherapy. FEBS Lett., 2007, 581(19), 3681-3688.
72. Bouchard, J. P.; Barbeau, A.; Bouchard, R.; Bouchard, R. W. Auto-somal recessive spastic ataxia of Charlevoix-Saguenay. Can. J. Neurol. Sci., 1978, 5(1), 61-69. (Pubitemid 8306199)
73. Engert, J. C.; Berube, P.; Mercier, J.; Dore, C.; Lepage, P.; Ge, B.; Bouchard, J. P.; Mathieu, J.; Melancon, S. B.; Schalling, M.; Lander, E. S.; Morgan, K.; Hudson, T. J.; Richter, A. ARSACS, a spastic ataxia common in northeastern Quebec, is caused by mutations in a new gene encoding an 11.5-kb ORF. Nat. Genet., 2000, 24(2), 120-125. (Pubitemid 30094710)
74. Takiyama, Y. Sacsinopathies: sacsin-related ataxia. Cerebellum, 2007, 28, 1-7.
75. Anderson, J. F.; Siller, E.; Barral, J. M. The sacsin repeating region (SRR): a novel Hsp90-related supra-domain associated with neu-rodegeneration. J. Mol. Biol., 2010, 400(4), 665-674.
76. Young, J. C.; Schneider, C.; Hartl, F. U. In vitro evidence that hsp90 contains two independent chaperone sites. FEBS Lett., 1997, 418(1-2), 139-143. (Pubitemid 27514433)
77. Vaughan, C. K.; Gohlke, U.; Sobott, F.; Good, V. M.; Ali, M. M.; Prodromou, C.; Robinson, C. V.; Saibil, H. R.; Pearl, L. H. Structure of an Hsp90-Cdc37-Cdk4 complex. Mol. Cell, 2006, 23(5), 697-707. (Pubitemid 44292559)
78. Parfitt, D. A.; Michael, G. J.; Vermeulen, E. G.; Prodromou, N. V.; Webb, T. R.; Gallo, J. M.; Cheetham, M. E.; Nicoll, W. S.; Blatch, G. L.; Chapple, J. P. The ataxia protein sacsin is a functional co-chaperone that protects against polyglutamine-expanded ataxin-1. Hum. Mol. Genet., 2009, 18(9), 1556-1565.
79. Lim, J.; Hao, T.; Shaw, C.; Patel, A. J.; Szabo, G.; Rual, J. F.; Fisk, C. J.; Li, N.; Smolyar, A.; Hill, D. E.; Barabasi, A. L.; Vidal, M.; Zoghbi, H. Y. A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell, 2006, 125(4), 801-814. (Pubitemid 43732348)
80. Clegg, H. V.; Itahana, K.; Zhang, Y. Unlocking the Mdm2-p53 loop: ubiquitin is the key. Cell Cycle, 2008, 7(3), 287-292. (Pubitemid 351366489)
81. Levav-Cohen, Y.; Haupt, S.; Haupt, Y. Mdm2 in growth signaling and cancer. Growth Factors, 2005, 23(3), 183-192. (Pubitemid 43203049)
82. Zenker, M.; Mayerle, J.; Lerch, M. M.; Tagariello, A.; Zerres, K.; Durie, P. R.; Beier, M.; Hulskamp, G.; Guzman, C.; Rehder, H.; Beemer, F. A.; Hamel, B.; Vanlieferinghen, P.; Gershoni-Baruch, R.; Vieira, M. W.; Dumic, M.; Auslender, R.; Gil-da-Silva-Lopes, V. L.; Steinlicht, S.; Rauh, M.; Shalev, S. A.; Thiel, C.; Ekici, A. B.; Winterpacht, A.; Kwon, Y. T.; Varshavsky, A.; Reis, A. Deficiency of UBR1, a ubiquitin ligase of the N-end rule pathway, causes pancreatic dysfunction, malformations and mental retardation (Johanson-Blizzard syndrome). Nat. Genet., 2005, 37(12), 1345-1350. (Pubitemid 41722190)
83. Bachmair, A.; Finley, D.; Varshavsky, A. In vivo half-life of a protein is a function of its amino-terminal residue. Science, 1986, 234(4773), 179-186. (Pubitemid 17186094)
84. Johanson, A.; Blizzard, R. A syndrome of congenital aplasia of the alae nasi, deafness, hypothyroidism, dwarfism, absent permanent teeth, and malabsorption. J. Pediatr, 1971, 79(6), 982-987.
85. Hurst, J. A.; Baraitser, M. Johanson-Blizzard syndrome. J. Med. Genet, 1989, 26(1), 45-48. (Pubitemid 19034693)
86. Rezaei, N.; Sabbaghian, M.; Liu, Z.; Zenker, M. Eponym : Johanson-Blizzard syndrome. Eur. J. Pediatr., 2010, 17.
87. Bachmair, A.; Varshavsky, A. The degradation signal in a shortlived protein. Cell, 1989, 56(6), 1019-1032.
88. Kwon, Y. T.; Reiss, Y.; Fried, V. A.; Hershko, A.; Yoon, J. K.; Gonda, D. K.; Sangan, P.; Copeland, N. G.; Jenkins, N. A.; Var-shavsky, A. The mouse and human genes encoding the recognition component of the N-end rule pathway. Proc. Natl. Acad. Sci. US , 1998, 95(14), 7898-7903.
89. Xia, Z.; Webster, A.; Du, F.; Piatkov, K.; Ghislain, M.; Var-shavsky, A. Substrate-binding sites of UBR1, the ubiquitin ligase of the N-end rule pathway. J. Biol. Chem., 2008, 283(35), 24011-24028.
90. Tasaki, T.; Kwon, Y. T. The mammalian N-end rule pathway: new insights into its components and physiological roles. Trends Bio-chem. Sci, 2007, 32(11), 520-528. (Pubitemid 350008070)
91. Nillegoda, N. B.; Theodoraki, M. A.; Mandal, A. K.; Mayo, K. J.; Ren, H. Y.; Sultana, R.; Wu, K.; Johnson, J.; Cyr, D. M.; Caplan, A. J. Ubr1 and ubr2 function in a quality control pathway for degradation of unfolded cytosolic proteins. Mol. Biol. Cell, 2010, 21(13), 2102-2116.
92. Jordanova, A.; Irobi, J.; Thomas, F. P.; Van Dijck, P.; Meerschaert, K.; Dewil, M.; Dierick, I.; Jacobs, A.; De Vriendt, E.; Guer-gueltcheva, V.; Rao, C. V.; Tournev, I.; Gondim, F. A.; D'Hooghe, M.; Van Gerwen, V.; Callaerts, P.; Van Den Bosch, L.; Timmermans, J. P.; Robberecht, W.; Gettemans, J.; Thevelein, J. M.; De Jonghe, P.; Kremensky, I.; Timmerman, V. Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat. Genet., 2006, 38(2), 197-202. (Pubitemid 43177233)
93. Scheper, G. C.; van der Klok, T.; van Andel, R. J.; van Berkel, C. G. ; Sissler, M.; Smet, J.; Muravina, T. I.; Serkov, S. V.; Uziel, G.; Bugiani, M.; Schiffmann, R.; Krageloh-Mann, I.; Smeitink, J. A.; Florentz, C.; Van Coster, R.; Pronk, J. C.; van der Knaap, M. S. Mitochondrial aspartyl-tRNA synthetase deficiency causes leu-koencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nat. Genet., 2007, 39(4), 534-539. (Pubitemid 46514784)
94. Edvardson, S.; Shaag, A.; Kolesnikova, O.; Gomori, J. M.; Tarassov, I.; Einbinder, T.; Saada, A.; Elpeleg, O. Deleterious mutation in the mitochondrial arginyl-transfer RNA synthetase gene is associated with pontocerebellar hypoplasia. Am. J. Hum. Genet., 2007, 81(4), 857-862. (Pubitemid 47596554)
95. Latour, P.; Thauvin-Robinet, C.; Baudelet-Mery, C.; Soichot, P.; Cusin, V.; Faivre, L.; Locatelli, M. C.; Mayencon, M.; Sarcey, A.; Broussolle, E.; Camu, W.; David, A.; Rousson, R. A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic AlanyltRNA synthetase is mutated in dominant axonal Char-cot-Marie-Tooth disease. Am. J. Hum. Genet., 2009, 86(1), 77-82.
96. Gazda, H. T.; Grabowska, A.; Merida-Long, L. B.; Latawiec, E.; Schneider, H. E.; Lipton, J. M.; Vlachos, A.; Atsidaftos, E.; Ball, S. E.; Orfali, K. A.; Niewiadomska, E.; Da Costa, L.; Tchernia, G.; Niemeyer, C.; Meerpohl, J. J.; Stahl, J.; Schratt, G.; Glader, B.; Backer, K.; Wong, C.; Nathan, D. G.; Beggs, A. H.; Sieff, C. A. Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia. Am. J. Hum. Genet., 2006, 79(6), 1110-1118. (Pubitemid 44868071)
97. Cmejla, R.; Cmejlova, J.; Handrkova, H.; Petrak, J.; Pospisilova, D. Ribosomal protein S17 gene (RPS17) is mutated in Diamond-Blackfan anemia. Hum. Mutat., 2007, 28(12), 1178-1182. (Pubitemid 350250381)
98. Farrar, J. E.; Nater, M.; Caywood, E.; McDevitt, M. A.; Kowalski, J.; Takemoto, C. M.; Talbot, C. C., Jr.; Meltzer, P.; Esposito, D.; Beggs, A. H.; Schneider, H. E.; Grabowska, A.; Ball, S. E.; Niewiadomska, E.; Sieff, C. A.; Vlachos, A.; Atsidaftos, E.; Ellis, S. R.; Lipton, J. M.; Gazda, H. T.; Arceci, R. J. Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia. Blood, 2008, 112(5), 1582-1592.
99. Gazda, H. T.; Sheen, M. R.; Vlachos, A.; Choesmel, V.; O'Donohue, M. F.; Schneider, H.; Darras, N.; Hasman, C.; Sieff, C. A.; Newburger, P. E.; Ball, S. E.; Niewiadomska, E.; Matysiak, M.; Zaucha, J. M.; Glader, B.; Niemeyer, C.; Meerpohl, J. J.; Atsidaftos, E.; Lipton, J. M.; Gleizes, P. E.; Beggs, A. H. Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients. Am. J. Hum. Genet., 2008, 83(6), 769-780.
100. Doherty, L.; Sheen, M. R.; Vlachos, A.; Choesmel, V.; O'Donohue, M. F.; Clinton, C.; Schneider, H. E.; Sieff, C. A.; Newburger, P. E.; Ball, S. E.; Niewiadomska, E.; Matysiak, M.; Glader, B.; Arceci, R. J.; Farrar, J. E.; Atsidaftos, E.; Lipton, J. M.; Gleizes, P. E.; Gazda, H. T. Ribosomal protein genes RPS10 and RPS26 are commonly mutated in Diamond-Blackfan anemia. Am. J. Hum. Genet., 2010, 86(2), 222-228.
101. Boocock, G. R.; Morrison, J. A.; Popovic, M.; Richards, N.; Ellis, L.; Durie, P. R.; Rommens, J. M. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat. Genet., 2003, 33(1), 97-101. (Pubitemid 36068690)
102. Ebert, B. L.; Pretz, J.; Bosco, J.; Chang, C. Y.; Tamayo, P.; Galili, N.; Raza, A.; Root, D. E.; Attar, E.; Ellis, S. R.; Golub, T. R. Identification of RPS14 as a 5q-syndrome gene by RNA interference screen. Nature, 2008, 451(7176), 335-339.
103. Heiss, N. S.; Knight, S. W.; Vulliamy, T. J.; Klauck, S. M.; Wiemann, S.; Mason, P. J.; Poustka, A.; Dokal, I. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat. Genet., 1998, 19(1), 32-38. (Pubitemid 28242019)
104. Ramser, J.; Ahearn, M. E.; Lenski, C.; Yariz, K. O.; Hellebrand, H.; von Rhein, M.; Clark, R. D.; Schmutzler, R. K.; Lichtner, P.; Hoffman, E. P.; Meindl, A.; Baumbach-Reardon, L. Rare missense and synonymous variants in UBE1 are associated with X-linked infantile spinal muscular atrophy. Am. J. Hum. Genet., 2008, 82(1), 188-193. (Pubitemid 351726086)
105. Hansen, J. J.; Durr, A.; Cournu-Rebeix, I.; Georgopoulos, C.; Ang, D. ; Nielsen, M. N.; Davoine, C. S.; Brice, A.; Fontaine, B.; Gre-gersen, N.; Bross, P. Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60. Am. J. Hum. Genet., 2002, 70(5), 1328-1332. (Pubitemid 34450582)
106. Magen, D.; Georgopoulos, C.; Bross, P.; Ang, D.; Segev, Y.; Gold-sher, D.; Nemirovski, A.; Shahar, E.; Ravid, S.; Luder, A.; Heno, B. ; Gershoni-Baruch, R.; Skorecki, K.; Mandel, H. Mitochondrial hsp60 chaperonopathy causes an autosomal-recessive neurodegen-erative disorder linked to brain hypomyelination and leukodystrophy. Am. J. Hum. Genet., 2008, 83(1), 30-42.
107. Vicart, P.; Caron, A.; Guicheney, P.; Li, Z.; Prevost, M. C.; Faure, A.; Chateau, D.; Chapon, F.; Tome, F.; Dupret, J. M.; Paulin, D.; Fardeau, M. A missense mutation in the alphaB-crystallin chaper-one gene causes a desmin-related myopathy. Nat. Genet., 1998, 20(1), 92-95. (Pubitemid 28410353)
108. Litt, M.; Kramer, P.; LaMorticella, D. M.; Murphey, W.; Lovrien, E. W.; Weleber, R. G. Autosomal dominant congenital cataract associated with a missense mutation in the human alpha crystallin gene CRYAA. Hum. Mol. Genet., 1998, 7(3), 471-474. (Pubitemid 28120638)
109. Sanjad, S. A.; Sakati, N. A.; Abu-Osba, Y. K.; Kaddoura, R.; Milner, R. D. A new syndrome of congenital hypoparathyroidism, severe growth failure, and dysmorphic features. Arch. Dis. Child, 1991, 66(2), 193-196.
110. Parvari, R.; Hershkovitz, E.; Grossman, N.; Gorodischer, R.; Loeys, B.; Zecic, A.; Mortier, G.; Gregory, S.; Sharony, R.; Kam-bouris, M.; Sakati, N.; Meyer, B. F.; Al Aqeel, A. I.; Al Humaidan, A. K.; Al Zanhrani, F.; Al Swaid, A.; Al Othman, J.; Diaz, G. A.; Weiner, R.; Khan, K. T.; Gordon, R.; Gelb, B. D. Mutation of TBCE causes hypoparathyroidism-retardation-dysmorphism and autosomal recessive Kenny-Caffey syndrome. Nat. Genet., 2002, 32(3), 448-452. (Pubitemid 35266124)
111. Diaz, G. A.; Gelb, B. D.; Ali, F.; Sakati, N.; Sanjad, S.; Meyer, B. F. ; Kambouris, M. Sanjad-Sakati and autosomal recessive Kenny-Caffey syndromes are allelic: evidence for an ancestral founder mutation and locus refinement. Am. J. Med. Genet., 1999, 85(1), 48-52. (Pubitemid 29256804)
112. Katsanis, N.; Beales, P. L.; Woods, M. O.; Lewis, R. A.; Green, J. S.; Parfrey, P. S.; Ansley, S. J.; Davidson, W. S.; Lupski, J. R. Mutations in MKKS cause obesity, retinal dystrophy and renal malformations associated with Bardet-Biedl syndrome. Nat. Genet., 2000, 26(1), 67-70.
113. Slavotinek, A. M.; Stone, E. M.; Mykytyn, K.; Heckenlively, J. R.; Green, J. S.; Heon, E.; Musarella, M. A.; Parfrey, P. S.; Sheffield, V. C.; Biesecker, L. G. Mutations in MKKS cause Bardet-Biedl syndrome. Nat. Genet., 2000, 26(1), 15-16.
114. Stone, D. L.; Slavotinek, A.; Bouffard, G. G.; Banerjee-Basu, S.; Baxevanis, A. D.; Barr, M.; Biesecker, L. G. Mutation of a gene encoding a putative chaperonin causes McKusick-Kaufman syndrome. Nat. Genet., 2000, 25(1), 79-82. (Pubitemid 30257041)
115. Evgrafov, O. V.; Mersiyanova, I.; Irobi, J.; Van Den Bosch, L.; Dierick, I.; Leung, C. L.; Schagina, O.; Verpoorten, N.; Van Impe, K.; Fedotov, V.; Dadali, E.; Auer-Grumbach, M.; Windpassinger, C. ; Wagner, K.; Mitrovic, Z.; Hilton-Jones, D.; Talbot, K.; Martin, J. J.; Vasserman, N.; Tverskaya, S.; Polyakov, A.; Liem, R. K.; Gettemans, J.; Robberecht, W.; De Jonghe, P.; Timmerman, V. Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nat. Genet., 2004, 36(6), 602-606. (Pubitemid 38715987)
116. Tang, B. S.; Zhao, G. H.; Luo, W.; Xia, K.; Cai, F.; Pan, Q.; Zhang, R. X.; Zhang, F. F.; Liu, X. M.; Chen, B.; Zhang, C.; Shen, L.; Ji-ang, H.; Long, Z. G.; Dai, H. P. Small heat-shock protein 22 mutated in autosomal dominant Charcot-Marie-Tooth disease type 2L. Hum. Genet., 2005, 116(3), 222-224. (Pubitemid 40174008)
117. Irobi, J.; Van Impe, K.; Seeman, P.; Jordanova, A.; Dierick, I.; Verpoorten, N.; Michalik, A.; De Vriendt, E.; Jacobs, A.; Van Gerwen, V.; Vennekens, K.; Mazanec, R.; Tournev, I.; Hilton-Jones, D.; Talbot, K.; Kremensky, I.; Van Den Bosch, L.; Rob-berecht, W.; Van Vandekerckhove, J.; Van Broeckhoven, C.; Get-temans, J.; De Jonghe, P.; Timmerman, V. Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy. Nat. Genet., 2004, 36(6), 597-601. (Pubitemid 38715986)
118. Bouhouche, A.; Benomar, A.; Bouslam, N.; Chkili, T.; Yahyaoui, M. Mutation in the epsilon subunit of the cytosolic chaperonin-containing t-complex peptide-1 (Cct5) gene causes autosomal re-cessive mutilating sensory neuropathy with spastic paraplegia. J. Med. Genet., 2006, 43(5), 441-443.
119. Ozelius, L. J.; Hewett, J. W.; Page, C. E.; Bressman, S. B.; Kramer, P. L.; Shalish, C.; de Leon, D.; Brin, M. F.; Raymond, D.; Corey, D. P.; Fahn, S.; Risch, N. J.; Buckler, A. J.; Gusella, J. F.; Breake-field, X. O. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat. Genet., 1997, 17(1), 40-48. (Pubitemid 27377530)
120. Burdette, A. J.; Churchill, P. F.; Caldwell, G. A.; Caldwell, K. A. The early-onset torsion dystonia-associated protein, torsinA, displays molecular chaperone activity in vitro. Cell Stress Chaperones, 2010, 19.
121. Chan, E. M.; Young, E. J.; Ianzano, L.; Munteanu, I.; Zhao, X.; Christopoulos, C. C.; Avanzini, G.; Elia, M.; Ackerley, C. A.; Jovic, N. J.; Bohlega, S.; Andermann, E.; Rouleau, G. A.; Delgado-Escueta, A. V.; Minassian, B. A.; Scherer, S. W. Mutations in NHLRC1 cause progressive myoclonus epilepsy. Nat. Genet., 2003, 35(2), 125-127. (Pubitemid 37187629)
122. Gentry, M. S.; Worby, C. A.; Dixon, J. E. Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin. Proc. Natl. Acad. Sci. USA, 2005, 102(24), 8501-8506. (Pubitemid 40862765)
123. Shimura, H.; Hattori, N.; Kubo, S.; Mizuno, Y.; Asakawa, S.; Minoshima, S.; Shimizu, N.; Iwai, K.; Chiba, T.; Tanaka, K.; Suzuki, T. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet., 2000, 25(3), 302-305. (Pubitemid 30437317)
124. Kitada, T.; Asakawa, S.; Hattori, N.; Matsumine, H.; Yamamura, Y.; Minoshima, S.; Yokochi, M.; Mizuno, Y.; Shimizu, N. Mutations in the parkin gene cause autosomal recessive juvenile parkin-sonism. Nature, 1998, 392(6676), 605-608. (Pubitemid 28207717)
125. Leroy, E.; Boyer, R.; Auburger, G.; Leube, B.; Ulm, G.; Mezey, E.; Harta, G.; Brownstein, M. J.; Jonnalagada, S.; Chernova, T.; Dehe-jia, A.; Lavedan, C.; Gasser, T.; Steinbach, P. J.; Wilkinson, K. D.; Polymeropoulos, M. H. The ubiquitin pathway in Parkinson's disease. Nature, 1998, 395(6701), 451-452.
126. Hashizume, R.; Fukuda, M.; Maeda, I.; Nishikawa, H.; Oyake, D.; Yabuki, Y.; Ogata, H.; Ohta, T. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. J. Biol. Chem., 2001, 276(18), 14537-14540.
127. Iwai, K.; Yamanaka, K.; Kamura, T.; Minato, N.; Conaway, R. C.; Conaway, J. W.; Klausner, R. D.; Pause, A. Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. Proc. Natl. Acad. Sci. USA, 1999, 96(22), 12436-12441. (Pubitemid 29513520)
128. Kishino, T.; Lalande, M.; Wagstaff, J. UBE3A/E6-AP mutations cause Angelman syndrome. Nat. Genet., 1997, 15(1), 70-73. (Pubitemid 27014952)
129. Lohr, N. J.; Molleston, J. P.; Strauss, K. A.; Torres-Martinez, W.; Sherman, E. A.; Squires, R. H.; Rider, N. L.; Chikwava, K. R.; Cummings, O. W.; Morton, D. H.; Puffenberger, E. G. Human ITCH E3 ubiquitin ligase deficiency causes syndromic multisystem autoimmune disease. Am. J. Hum. Genet., 2010, 86(3), 447-453.
130. Frosk, P.; Weiler, T.; Nylen, E.; Sudha, T.; Greenberg, C. R.; Morgan, K.; Fujiwara, T. M.; Wrogemann, K. Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene. Am. J. Hum. Genet., 2002, 70(3), 663-672. (Pubitemid 34177921)
131. Locke, M.; Tinsley, C. L.; Benson, M. A.; Blake, D. J. TRIM32 is an E3 ubiquitin ligase for dysbindin. Hum. Mol. Genet., 2009, 18(13), 2344-2358.
132. Schoser, B. G.; Frosk, P.; Engel, A. G.; Klutzny, U.; Lochmuller, H.; Wrogemann, K. Commonality of TRIM32 mutation in causing sarcotubular myopathy and LGMD2H. Ann. Neurol., 2005, 57(4), 591-595. (Pubitemid 40471176)
133. Chiang, A. P.; Beck, J. S.; Yen, H. J.; Tayeh, M. K.; Scheetz, T. E.; Swiderski, R. E.; Nishimura, D. Y.; Braun, T. A.; Kim, K. Y.; Huang, J.; Elbedour, K.; Carmi, R.; Slusarski, D. C.; Casavant, T. L.; Stone, E. M.; Sheffield, V. C. Homozygosity mapping with SNP arrays identifies TRIM32, an E3 ubiquitin ligase, as a Bardet-Biedl syndrome gene (BBS11). Proc. Natl. Acad. Sci. USA, 2006, 103(16), 6287-6292.
134. Huber, C.; Dias-Santagata, D.; Glaser, A.; O'Sullivan, J.; Brauner, R.; Wu, K.; Xu, X.; Pearce, K.; Wang, R.; Uzielli, M. L.; Dagoneau, N.; Chemaitilly, W.; Superti-Furga, A.; Dos Santos, H.; Megarbane, A.; Morin, G.; Gillessen-Kaesbach, G.; Hennekam, R.; Van der Burgt, I.; Black, G. C.; Clayton, P. E.; Read, A.; Le Merrer, M.; Scambler, P. J.; Munnich, A.; Pan, Z. Q.; Winter, R.; Cormier-Daire, V. Identification of mutations in CUL7 in 3-M syndrome. Nat. Genet., 2005, 37(10), 1119-1124. (Pubitemid 41486666)
135. Nagamine, K.; Peterson, P.; Scott, H. S.; Kudoh, J.; Minoshima, S.; Heino, M.; Krohn, K. J.; Lalioti, M. D.; Mullis, P. E.; Antonarakis, S. E.; Kawasaki, K.; Asakawa, S.; Ito, F.; Shimizu, N. Positional cloning of the APECED gene. Nat. Genet., 1997, 17(4), 393-398. (Pubitemid 27518386)
136. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat. Genet., 1997, 17(4), 399-403.
137. Uchida, D.; Hatakeyama, S.; Matsushima, A.; Han, H.; Ishido, S.; Hotta, H.; Kudoh, J.; Shimizu, N.; Doucas, V.; Nakayama, K. I.; Kuroda, N.; Matsumoto, M. AIRE functions as an E3 ubiquitin ligase. J. Exp. Med., 2004, 199(2), 167-172. (Pubitemid 38129697)
138. Meetei, A. R.; de Winter, J. P.; Medhurst, A. L.; Wallisch, M.; Waisfisz, Q.; van de Vrugt, H. J.; Oostra, A. B.; Yan, Z.; Ling, C.; Bishop, C. E.; Hoatlin, M. E.; Joenje, H.; Wang, W. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat. Genet., 2003, 35(2), 165-170. (Pubitemid 37187635)
139. Quaderi, N. A.; Schweiger, S.; Gaudenz, K.; Franco, B.; Rugarli, E. I.; Berger, W.; Feldman, G. J.; Volta, M.; Andolfi, G.; Gilgenk-rantz, S.; Marion, R. W.; Hennekam, R. C.; Opitz, J. M.; Muenke, M.; Ropers, H. H.; Ballabio, A. Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22. Nat. Genet., 1997, 17(3), 285-291. (Pubitemid 27475990)
140. Trockenbacher, A.; Suckow, V.; Foerster, J.; Winter, J.; Krauss, S.; Ropers, H. H.; Schneider, R.; Schweiger, S. MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phospha-tase 2A for degradation. Nat. Genet., 2001, 29(3), 287-294. (Pubitemid 33096453)
141. Nascimento, R. M.; Otto, P. A.; de Brouwer, A. P.; Vianna-Morgante, A. M. UBE2A, which encodes a ubiquitin-conjugating enzyme, is mutated in a novel X-linked mental retardation syndrome. Am. J. Hum. Genet., 2006, 79(3), 549-555. (Pubitemid 44384264)
142. Di Bella, D.; Lazzaro, F.; Brusco, A.; Plumari, M.; Battaglia, G.; Pastore, A.; Finardi, A.; Cagnoli, C.; Tempia, F.; Frontali, M.; Veneziano, L.; Sacco, T.; Boda, E.; Brussino, A.; Bonn, F.; Castel-lotti, B.; Baratta, S.; Mariotti, C.; Gellera, C.; Fracasso, V.; Magri, S.; Langer, T.; Plevani, P.; Di Donato, S.; Muzi-Falconi, M.; Taroni, F. Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28. Nat. Genet., 2010, 42(4), 313-321.
143. Casari, G.; De Fusco, M.; Ciarmatori, S.; Zeviani, M.; Mora, M.; Fernandez, P.; De Michele, G.; Filla, A.; Cocozza, S.; Marconi, R.; Durr, A.; Fontaine, B.; Ballabio, A. Spastic paraplegia and OX-PHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell, 1998, 93(6), 973-983. (Pubitemid 28280791)
144. Evans, K. J.; Gomes, E. R.; Reisenweber, S. M.; Gundersen, G. G.; Lauring, B. P. Linking axonal degeneration to microtubule remodeling by Spastin-mediated microtubule severing. J. Cell Biol., 2005, 168(4), 599-606. (Pubitemid 40271025)
145. Hazan, J.; Fonknechten, N.; Mavel, D.; Paternotte, C.; Samson, D.; Artiguenave, F.; Davoine, C. S.; Cruaud, C.; Durr, A.; Wincker, P.; Brottier, P.; Cattolico, L.; Barbe, V.; Burgunder, J. M.; Prud'homme, J. F.; Brice, A.; Fontaine, B.; Heilig, B.; Weissenbach, J. Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia. Nat. Genet., 1999, 23(3), 296-303. (Pubitemid 29526426)